Stem cells are primarily sourced from embryos, not infants, as they are pluripotent and can develop into any cell type in the body. However, embryonic stem cells are limited in availability due to their extraction from discarded IVF embryos. Adult stem cells exist in the body but are not pluripotent, restricting their regenerative capabilities. Research into inducible pluripotent stem cells (iPSCs) is promising, as these are normal cells reprogrammed to behave like embryonic stem cells. Despite potential risks, such as cancerous mutations from current reprogramming techniques, advancements are being made to improve efficiency and safety. The future of stem cell research holds significant potential for medical breakthroughs, particularly in tissue engineering and regenerative medicine.